{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T00:54:36Z","timestamp":1775868876043,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the S&T Program of Hebei","award":["19277701D"],"award-info":[{"award-number":["19277701D"]}]},{"DOI":"10.13039\/501100003787","name":"Hebei Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["H2019106063"],"award-info":[{"award-number":["H2019106063"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shijiazhuang Science and Technology Bureau","award":["201460603"],"award-info":[{"award-number":["201460603"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Thymoma is the most common malignant tumor in thymic epithelial tumors (TETS). This study aimed to identify the changes in serum proteomics in patients with thymoma. Proteins were extracted from twenty patients with thymoma serum and nine healthy controls and prepared for mass spectrometry (MS) analysis. Data independent acquisition (DIA) quantitative proteomics technique was used to examine the serum proteome. Differential proteins of abundance changes in the serum were identified. Bioinformatics was used to examine the differential proteins. Functional tagging and enrichment analysis were conducted using the Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) databases. The string database was used to assess the interaction of different proteins. In all, 486 proteins were found in all samples. There were differences in 58 serum proteins between patients and healthy blood donors, 35 up-regulated and 23 down-regulated. These proteins are primarily exocrine and serum membrane proteins involved in controlling immunological responses and antigen binding, according to GO functional annotation. KEGG functional annotation showed that these proteins play a significant role in the complement and coagulation cascade and the phosphoinositide 3-kinase (PI3K)\/protein kinase B (AKT) signal pathway. Notably, the KEGG pathway (complement and coagulation cascade) is enriched, and three key activators were up-regulated: von willebrand factor (VWF), coagulation factor v (F5) and vitamin k-dependent protein c (PC). Protein\u2013protein interaction (PPI) analysis showed that six proteins ((VWF, F5, thrombin reactive protein 1 (THBS1), mannose-binding lectin-associated serine protease 2 (MASP2), apolipoprotein B (APOB), and apolipoprotein (a) (LPA)) were up-regulated and two proteins (Metalloproteinase inhibitor 1(TIMP1), ferritin light chain (FTL)) were down-regulated. The results of this study showed that several proteins involved in complement and coagulation cascades were up-regulated in the serum of patients.<\/jats:p>","DOI":"10.1038\/s41598-023-32339-4","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T10:02:54Z","timestamp":1680084174000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Proteomics analysis of serum from thymoma patients"],"prefix":"10.1038","volume":"13","author":[{"given":"Jiaduo","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoyan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,29]]},"reference":[{"key":"32339_CR1","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.1097\/JTO.0000000000000297","volume":"9","author":"MA den Bakker","year":"2014","unstructured":"den Bakker, M. A., Roden, A. C., Marx, A. & Marino, M. Histologic classification of thymoma: A practical guide for routine cases. J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer 9, S125-130. https:\/\/doi.org\/10.1097\/JTO.0000000000000297 (2014).","journal-title":"J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer"},{"key":"32339_CR2","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1056\/NEJMra1602678","volume":"375","author":"NE Gilhus","year":"2016","unstructured":"Gilhus, N. E. Myasthenia gravis. N. Engl. J. Med. 375, 2570\u20132581. https:\/\/doi.org\/10.1056\/NEJMra1602678 (2016).","journal-title":"N. Engl. J. Med."},{"key":"32339_CR3","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1097\/JTO.0000000000000663","volume":"10","author":"WD Travis","year":"2015","unstructured":"Travis, W. D., Brambilla, E., Burke, A. P., Marx, A. & Nicholson, A. G. Introduction to the 2015 world health organization classification of tumors of the lung, pleura, thymus, and heart. J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer 10, 1240\u20131242. https:\/\/doi.org\/10.1097\/JTO.0000000000000663 (2015).","journal-title":"J. Thorac. Oncol. Off. Publ. Int. Assoc. Study Lung Cancer"},{"key":"32339_CR4","doi-asserted-by":"publisher","unstructured":"Marx, A., & Str\u00f6bel, P. Update on thymoma pathology. Lessons from molecular and translational studies. Ann. Pathol. 29(1), S22\u2013S24 (2009). https:\/\/doi.org\/10.1016\/j.annpat.2009.07.016.","DOI":"10.1016\/j.annpat.2009.07.016"},{"key":"32339_CR5","doi-asserted-by":"publisher","first-page":"6790","DOI":"10.1158\/1078-0432.CCR-09-0644","volume":"15","author":"N Girard","year":"2009","unstructured":"Girard, N. et al. Comprehensive genomic analysis reveals clinically relevant molecular distinctions between thymic carcinomas and thymomas. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 15, 6790\u20136799. https:\/\/doi.org\/10.1158\/1078-0432.CCR-09-0644 (2009).","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"32339_CR6","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/modpathol.2009.105","volume":"22","author":"M Kojika","year":"2009","unstructured":"Kojika, M. et al. Immunohistochemical differential diagnosis between thymic carcinoma and type B3 thymoma: diagnostic utility of hypoxic marker, GLUT-1, in thymic epithelial neoplasms. Mod. Pathol. Off. J. U S Can. Acad. Pathol. 22, 1341\u20131350. https:\/\/doi.org\/10.1038\/modpathol.2009.105 (2009).","journal-title":"Mod. Pathol. Off. J. U S Can. Acad. Pathol."},{"key":"32339_CR7","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1158\/1078-0432.CCR-12-3260","volume":"19","author":"I Petrini","year":"2013","unstructured":"Petrini, I. et al. Copy number aberrations of genes regulating normal thymus development in thymic epithelial tumors. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 19, 1960\u20131971. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-3260 (2013).","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"32339_CR8","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/bjc.2015.425","volume":"114","author":"M Radovich","year":"2016","unstructured":"Radovich, M. et al. A large microRNA cluster on chromosome 19 is a transcriptional hallmark of WHO type A and AB thymomas. Br. J. Cancer 114, 477\u2013484 (2016).","journal-title":"Br. J. Cancer"},{"key":"32339_CR9","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/his.13114","volume":"70","author":"F Pfister","year":"2017","unstructured":"Pfister, F. et al. Vascular architecture as a diagnostic marker for differentiation of World Health Organization thymoma subtypes and thymic carcinoma. Histopathology 70, 693\u2013703. https:\/\/doi.org\/10.1111\/his.13114 (2017).","journal-title":"Histopathology"},{"key":"32339_CR10","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jchromb.2006.09.004","volume":"847","author":"TD Veenstra","year":"2007","unstructured":"Veenstra, T. D. Global and targeted quantitative proteomics for biomarker discovery. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 847, 3\u201311. https:\/\/doi.org\/10.1016\/j.jchromb.2006.09.004 (2007).","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"32339_CR11","first-page":"2811","volume":"125","author":"Q-L Sun","year":"2012","unstructured":"Sun, Q.-L. et al. Proteome analysis and tissue array for profiling protein markers associated with type B thymoma subclassification. Chin. Med. J. (Engl) 125, 2811\u20132818 (2012).","journal-title":"Chin. Med. J. (Engl)"},{"key":"32339_CR12","doi-asserted-by":"publisher","first-page":"e0166494","DOI":"10.1371\/journal.pone.0166494","volume":"11","author":"L Wang","year":"2016","unstructured":"Wang, L., Branson, O. E., Shilo, K., Hitchcock, C. L. & Freitas, M. A. Proteomic signatures of thymomas. PLoS ONE 11, e0166494 (2016).","journal-title":"PLoS ONE"},{"key":"32339_CR13","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1039\/C8AN00218E","volume":"143","author":"T Zhao","year":"2018","unstructured":"Zhao, T. et al. Diagnosis of thymic epithelial tumor subtypes by a quantitative proteomic approach. Analyst 143, 2491\u20132500 (2018).","journal-title":"Analyst"},{"key":"32339_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"key":"32339_CR15","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44, D457\u2013D462. https:\/\/doi.org\/10.1093\/nar\/gkv1070 (2016).","journal-title":"Nucleic Acids Res."},{"key":"32339_CR16","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1172\/JCI112069","volume":"76","author":"W Savino","year":"1985","unstructured":"Savino, W. et al. Thymoma epithelial cells secrete thymic hormone but do not express class II antigens of the major histocompatibility complex. J. Clin. Invest. 76, 1140\u20131146. https:\/\/doi.org\/10.1172\/JCI112069 (1985).","journal-title":"J. Clin. Invest."},{"key":"32339_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/s0304-3835(01)00633-4","volume":"172","author":"H Sasaki","year":"2001","unstructured":"Sasaki, H. et al. Serum level of the periostin, a homologue of an insect cell adhesion molecule, in thymoma patients. Cancer Lett. 172, 37\u201342. https:\/\/doi.org\/10.1016\/s0304-3835(01)00633-4 (2001).","journal-title":"Cancer Lett."},{"key":"32339_CR18","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.prp.2016.09.005","volume":"212","author":"MJ Du","year":"2016","unstructured":"Du, M. J., Shen, Q., Yin, H., Rao, Q. & Zhou, M. X. Diagnostic roles of MUC1 and GLUT1 in differentiating thymic carcinoma from type B3 thymoma. Pathol. Res. Pract. 212, 1048\u20131051. https:\/\/doi.org\/10.1016\/j.prp.2016.09.005 (2016).","journal-title":"Pathol. Res. Pract."},{"key":"32339_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0028-1087142","volume":"5","author":"RL Bick","year":"1978","unstructured":"Bick, R. L. Alterations of hemostasis associated with malignancy: Etiology, pathophysiology, diagnosis and management. Semin. Thromb. Hemost. 5, 1\u201326. https:\/\/doi.org\/10.1055\/s-0028-1087142 (1978).","journal-title":"Semin. Thromb. Hemost."},{"key":"32339_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/s1470-2045(01)00619-2","volume":"3","author":"GYH Lip","year":"2002","unstructured":"Lip, G. Y. H., Chin, B. S. P. & Blann, A. D. Cancer and the prothrombotic state. Lancet Oncol. 3, 27\u201334. https:\/\/doi.org\/10.1016\/s1470-2045(01)00619-2 (2002).","journal-title":"Lancet Oncol."},{"key":"32339_CR21","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1055\/s-0039-1688495","volume":"45","author":"HC Kwaan","year":"2019","unstructured":"Kwaan, H. C. & Lindholm, P. F. Fibrin and fibrinolysis in cancer. Semin. Thromb. Hemost. 45, 413\u2013422. https:\/\/doi.org\/10.1055\/s-0039-1688495 (2019).","journal-title":"Semin. Thromb. Hemost."},{"key":"32339_CR22","first-page":"1","volume":"149","author":"DR Senger","year":"1996","unstructured":"Senger, D. R. Molecular framework for angiogenesis: a complex web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines. Am. J. Pathol. 149, 1\u20137 (1996).","journal-title":"Am. J. Pathol."},{"key":"32339_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1160\/th11-06-0431","volume":"107","author":"TJ Cramer","year":"2012","unstructured":"Cramer, T. J. & Gale, A. J. The anticoagulant function of coagulation factor V. Thromb. Haemost. 107, 15\u201321. https:\/\/doi.org\/10.1160\/th11-06-0431 (2012).","journal-title":"Thromb. Haemost."},{"issue":"Suppl 1","key":"32339_CR24","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1016\/s0049-3848(16)30098-6","volume":"140","author":"M Tinholt","year":"2016","unstructured":"Tinholt, M., Sandset, P. M. & Iversen, N. Polymorphisms of the coagulation system and risk of cancer. Thromb. Res. 140(Suppl 1), S49-54. https:\/\/doi.org\/10.1016\/s0049-3848(16)30098-6 (2016).","journal-title":"Thromb. Res."},{"key":"32339_CR25","doi-asserted-by":"publisher","first-page":"1824644","DOI":"10.1080\/2162402X.2020.1824644","volume":"9","author":"M Tinholt","year":"2020","unstructured":"Tinholt, M. et al. Coagulation factor V is a marker of tumor-infiltrating immune cells in breast cancer. Oncoimmunology 9, 1824644 (2020).","journal-title":"Oncoimmunology"},{"key":"32339_CR26","doi-asserted-by":"publisher","first-page":"84546","DOI":"10.18632\/oncotarget.19165","volume":"8","author":"T Huang","year":"2017","unstructured":"Huang, T., Sun, L., Yuan, X. & Qiu, H. Thrombospondin-1 is a multifaceted player in tumor progression. Oncotarget 8, 84546\u201384558. https:\/\/doi.org\/10.18632\/oncotarget.19165 (2017).","journal-title":"Oncotarget"},{"key":"32339_CR27","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3389\/fphar.2015.00252","volume":"6","author":"A Jeanne","year":"2015","unstructured":"Jeanne, A., Schneider, C., Martiny, L. & Dedieu, S. Original insights on thrombospondin-1-related antireceptor strategies in cancer. Front. Pharmacol. 6, 252. https:\/\/doi.org\/10.3389\/fphar.2015.00252 (2015).","journal-title":"Front. Pharmacol."},{"key":"32339_CR28","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41375-019-0622-6","volume":"34","author":"H Kamijo","year":"2020","unstructured":"Kamijo, H. et al. Thrombospondin-1 promotes tumor progression in cutaneous T-cell lymphoma via CD47. Leukemia 34, 845\u2013856. https:\/\/doi.org\/10.1038\/s41375-019-0622-6 (2020).","journal-title":"Leukemia"},{"key":"32339_CR29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2152\/jmi.60.91","volume":"60","author":"H Horiguchi","year":"2013","unstructured":"Horiguchi, H., Yamagata, S., Rong Qian, Z., Kagawa, S. & Sakashita, N. Thrombospondin-1 is highly expressed in desmoplastic components of invasive ductal carcinoma of the breast and associated with lymph node metastasis. J. Med. Investig. JMI 60, 91\u201396. https:\/\/doi.org\/10.2152\/jmi.60.91 (2013).","journal-title":"J. Med. Investig. JMI"},{"key":"32339_CR30","doi-asserted-by":"publisher","first-page":"5782","DOI":"10.18632\/oncotarget.2164","volume":"5","author":"A Jayachandran","year":"2014","unstructured":"Jayachandran, A. et al. Thrombospondin 1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in human melanoma. Oncotarget 5, 5782\u20135797. https:\/\/doi.org\/10.18632\/oncotarget.2164 (2014).","journal-title":"Oncotarget"},{"key":"32339_CR31","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/jop.12430","volume":"45","author":"SK Pal","year":"2016","unstructured":"Pal, S. K. et al. THBS1 is induced by TGFB1 in the cancer stroma and promotes invasion of oral squamous cell carcinoma. J. Oral. Pathol. Med. Off. Publ. Int. Assoc. Oral Pathol. Am. Acad. Oral. Pathol. 45, 730\u2013739. https:\/\/doi.org\/10.1111\/jop.12430 (2016).","journal-title":"J. Oral. Pathol. Med. Off. Publ. Int. Assoc. Oral Pathol. Am. Acad. Oral. Pathol."},{"key":"32339_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/j.1600-065x.1998.tb01185.x","volume":"163","author":"WI Weis","year":"1998","unstructured":"Weis, W. I., Taylor, M. E. & Drickamer, K. The C-type lectin superfamily in the immune system. Immunol. Rev. 163, 19\u201334. https:\/\/doi.org\/10.1111\/j.1600-065x.1998.tb01185.x (1998).","journal-title":"Immunol. Rev."},{"key":"32339_CR33","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/386506a0","volume":"386","author":"S Thiel","year":"1997","unstructured":"Thiel, S. et al. A second serine protease associated with mannan-binding lectin that activates complement. Nature 386, 506\u2013510. https:\/\/doi.org\/10.1038\/386506a0 (1997).","journal-title":"Nature"},{"key":"32339_CR34","doi-asserted-by":"publisher","first-page":"26058","DOI":"10.1074\/jbc.M401318200","volume":"279","author":"C-B Chen","year":"2004","unstructured":"Chen, C.-B. & Wallis, R. Two mechanisms for mannose-binding protein modulation of the activity of its associated serine proteases. J. Biol. Chem. 279, 26058\u201326065. https:\/\/doi.org\/10.1074\/jbc.M401318200 (2004).","journal-title":"J. Biol. Chem."},{"key":"32339_CR35","first-page":"305","volume":"2","author":"MW Turner","year":"2000","unstructured":"Turner, M. W. & Hamvas, R. M. Mannose-binding lectin: structure, function, genetics and disease associations. Rev. Immunogenet. 2, 305\u2013322 (2000).","journal-title":"Rev. Immunogenet."},{"key":"32339_CR36","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1158\/1078-0432.ccr-04-1272","volume":"11","author":"H Ytting","year":"2005","unstructured":"Ytting, H., Christensen, I. J., Thiel, S., Jensenius, J. C. & Nielsen, H. J. Serum mannan-binding lectin-associated serine protease 2 levels in colorectal cancer: Relation to recurrence and mortality. Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. 11, 1441\u20131446. https:\/\/doi.org\/10.1158\/1078-0432.ccr-04-1272 (2005).","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"32339_CR37","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1186\/s12859-020-03691-3","volume":"21","author":"T Zengin","year":"2020","unstructured":"Zengin, T. & \u00d6nal-S\u00fczek, T. Analysis of genomic and transcriptomic variations as prognostic signature for lung adenocarcinoma. BMC Bioinformatics 21, 368. https:\/\/doi.org\/10.1186\/s12859-020-03691-3 (2020).","journal-title":"BMC Bioinformatics"},{"key":"32339_CR38","doi-asserted-by":"publisher","first-page":"101934","DOI":"10.1016\/j.canep.2021.101934","volume":"73","author":"P Sun","year":"2021","unstructured":"Sun, P. et al. Distinct clinical and genetic mutation characteristics in sporadic and Lynch syndrome-associated endometrial cancer in a Chinese population. Cancer Epidemiol. 73, 101934. https:\/\/doi.org\/10.1016\/j.canep.2021.101934 (2021).","journal-title":"Cancer Epidemiol."},{"key":"32339_CR39","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.21037\/tlcr-22-467","volume":"11","author":"M Bao","year":"2022","unstructured":"Bao, M. et al. Proteomic analysis of plasma exosomes in patients with non-small cell lung cancer. Transl. Lung Cancer Res. 11, 1434\u20131452. https:\/\/doi.org\/10.21037\/tlcr-22-467 (2022).","journal-title":"Transl. Lung Cancer Res."},{"key":"32339_CR40","doi-asserted-by":"publisher","first-page":"E9739","DOI":"10.3390\/ijms21249739","volume":"21","author":"GA Cabral-Pacheco","year":"2020","unstructured":"Cabral-Pacheco, G. A. et al. The roles of matrix metalloproteinases and their inhibitors in human diseases. Int. J. Mol. Sci. 21, E9739. https:\/\/doi.org\/10.3390\/ijms21249739 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"32339_CR41","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1146\/annurev.cb.09.110193.002545","volume":"9","author":"WG Stetler-Stevenson","year":"1993","unstructured":"Stetler-Stevenson, W. G., Aznavoorian, S. & Liotta, L. A. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol. 9, 541\u2013573. https:\/\/doi.org\/10.1146\/annurev.cb.09.110193.002545 (1993).","journal-title":"Annu. Rev. Cell Biol."},{"key":"32339_CR42","doi-asserted-by":"publisher","first-page":"871","DOI":"10.3892\/or.7.4.871","volume":"7","author":"H Inoue","year":"2000","unstructured":"Inoue, H. et al. Expression of tissue inhibitor of matrix metalloproteinase-1 in human breast carcinoma. Oncol. Rep. 7, 871\u2013874. https:\/\/doi.org\/10.3892\/or.7.4.871 (2000).","journal-title":"Oncol. Rep."},{"key":"32339_CR43","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1054\/bjoc.2001.1854","volume":"85","author":"LL Groft","year":"2001","unstructured":"Groft, L. L. et al. Differential expression and localization of TIMP-1 and TIMP-4 in human gliomas. Br. J. Cancer 85, 55\u201363. https:\/\/doi.org\/10.1054\/bjoc.2001.1854 (2001).","journal-title":"Br. J. Cancer"},{"key":"32339_CR44","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/1471-2407-9-322","volume":"9","author":"A-S Schrohl","year":"2009","unstructured":"Schrohl, A.-S., Look, M. P., Meijer-van Gelder, M. E., Foekens, J. A. & Br\u00fcnner, N. Tumor tissue levels of Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and outcome following adjuvant chemotherapy in premenopausal lymph node-positive breast cancer patients: A retrospective study. BMC Cancer 9, 322. https:\/\/doi.org\/10.1186\/1471-2407-9-322 (2009).","journal-title":"BMC Cancer"},{"key":"32339_CR45","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1038\/bjc.2014.462","volume":"111","author":"R Roy","year":"2014","unstructured":"Roy, R. et al. Urinary TIMP-1 and MMP-2 levels detect the presence of pancreatic malignancies. Br. J. Cancer 111, 1772\u20131779. https:\/\/doi.org\/10.1038\/bjc.2014.462 (2014).","journal-title":"Br. J. Cancer"},{"key":"32339_CR46","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/jop.12270","volume":"44","author":"M Bodnar","year":"2015","unstructured":"Bodnar, M., Szylberg, \u0141, Kazmierczak, W. & Marszalek, A. Tumor progression driven by pathways activating matrix metalloproteinases and their inhibitors. J. Oral. Pathol. Med. Off. Publ. Int. Assoc. Oral. Pathol. Am. Acad. Oral. Pathol. 44, 437\u2013443. https:\/\/doi.org\/10.1111\/jop.12270 (2015).","journal-title":"J. Oral. Pathol. Med. Off. Publ. Int. Assoc. Oral. Pathol. Am. Acad. Oral. Pathol."},{"key":"32339_CR47","doi-asserted-by":"publisher","first-page":"8277","DOI":"10.1007\/s13277-015-3564-2","volume":"36","author":"I Lugowska","year":"2015","unstructured":"Lugowska, I. et al. Serum markers in early-stage and locally advanced melanoma. Tumour Biol. J. Int. Soc. Oncodev. Biol. Med. 36, 8277\u20138285. https:\/\/doi.org\/10.1007\/s13277-015-3564-2 (2015).","journal-title":"Tumour Biol. J. Int. Soc. Oncodev. Biol. Med."},{"key":"32339_CR48","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.cca.2009.09.015","volume":"409","author":"Y-C Yi","year":"2009","unstructured":"Yi, Y.-C. et al. Genetic polymorphism of the tissue inhibitor of metalloproteinase-1 is associated with an increased risk of endometrial cancer. Clin. Chim. Acta Int. J. Clin. Chem. 409, 127\u2013131. https:\/\/doi.org\/10.1016\/j.cca.2009.09.015 (2009).","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"32339_CR49","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S0022-4804(02)00040-9","volume":"109","author":"H Yukiue","year":"2003","unstructured":"Yukiue, H. et al. Clinical significance of tissue inhibitor of metalloproteinase and matrix metalloproteinase mRNA expression in thymoma. J. Surg. Res. 109, 86\u201391. https:\/\/doi.org\/10.1016\/S0022-4804(02)00040-9 (2003).","journal-title":"J. Surg. Res."},{"key":"32339_CR50","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/s0006-291x(02)00741-6","volume":"296","author":"T Wang","year":"2002","unstructured":"Wang, T., Yamashita, K., Iwata, K. & Hayakawa, T. Both tissue inhibitors of metalloproteinases-1 (TIMP-1) and TIMP-2 activate Ras but through different pathways. Biochem. Biophys. Res. Commun. 296, 201\u2013205. https:\/\/doi.org\/10.1016\/s0006-291x(02)00741-6 (2002).","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32339-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32339-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32339-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T10:13:52Z","timestamp":1680084832000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-32339-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,29]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["32339"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-32339-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,29]]},"assertion":[{"value":"11 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5117"}}